gastrografin
bayer hellas s.a 6-8 agisilaou street 151 23 marousi attiki, , greece - meglumine amidotrizoate, sodium amidotrizoate - gastroenteral solution - sodium amidotrizoate 10 g/100ml meglumine amidotrizoate 66 g/100ml - contrast media
gastrografin
bayer plc - meglumine amidotrizoate; sodium amidotrizoate - gastroenteral solution - meglumine amidotrizoate 660 mg/ml; sodium amidotrizoate 100 mg/ml - contrast media
gastrografin oral solution
bayer plc - sodium amidotrizoate; meglumine amidotrizoate - oral solution - 100mg/1ml ; 660mg/1ml
urografin 150 solution for injection 10ml ampoules
bayer plc - meglumine amidotrizoate; sodium amidotrizoate - solution for injection - 260mg/1ml ; 40mg/1ml
urografin 150 solution for injection 20ml ampoules
bayer plc - sodium amidotrizoate; meglumine amidotrizoate - solution for injection - 40mg/1ml ; 260mg/1ml
gastrografin solution
bayer (south east asia) pte ltd - meglumine amidotrizoate; sodium amidotrizoate - solution - 0.66 g/ml - meglumine amidotrizoate 0.66 g/ml; sodium amidotrizoate 0.1 g/ml
ioscan sodium amidotrizoate 370.5 mg/ml oral solution bottle
iotech pty ltd - sodium amidotrizoate, quantity: 370.5 mg/ml - oral liquid, solution - excipient ingredients: sorbitol; acesulfame potassium; quinoline yellow; methyl hydroxybenzoate; citric acid; purified water; flavour - ioscan is a contrast medium for computerised axial tomograpghy examination of the gastrointestinal tract. it should be made up with water prior to use, and administered orally. it is indicated primarily for use when barium sulphate is not appropriate.
ioscan sodium amidotrizoate 3.705 g/10 ml oral liquid sachet
iotech pty ltd - sodium amidotrizoate, quantity: 3.705 g - oral liquid, solution - excipient ingredients: sorbitol; acesulfame potassium; quinoline yellow; methyl hydroxybenzoate; citric acid; purified water; flavour - ioscan is a contrast medium for computerised axial tomograpghy examination of the gastrointestinal tract. it should be made up with water prior to use, and administered orally. it is indicated primarily for use when barium sulphate is not appropriate.
sodium chloride 0.9 % intravenous infusion bp
teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.
sodium chloride 0.9 % intravenous infusion bp
teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.